Medication-Assisted Treatment Is Becoming a Core Jail and Prison Health Issue in New Mexico

Medication-assisted treatment, often called MAT and increasingly referred to as medication for opioid use disorder, or MOUD, is now a major part of correctional health policy in New Mexico. In simple terms, MAT uses FDA-approved medications, often alongside counseling and recovery support, to treat substance use disorders, especially opioid use disorder. In jails and prisons, the goal is not only to manage withdrawal, but also to reduce overdose risk, support stability during incarceration, and improve outcomes after release.

As of today, New Mexico stands out because it has moved beyond discussion and into implementation. State rules adopted in 2024 set deadlines for correctional facilities, and the New Mexico Corrections Department has since launched pilot and maintenance programs. That makes New Mexico one of the more active states in the country on this issue, although the rollout is still evolving and not every facility may be at the same stage.

Why MAT in Correctional Settings Matters

People entering jail or prison often arrive with untreated or partially treated opioid use disorder, alcohol use disorder, or other substance use disorders. Forced interruption of treatment can lead to withdrawal, relapse, and a much higher overdose risk after release. MAT helps address that gap by continuing treatment for people already on medication and, in some cases, starting treatment for people who qualify while incarcerated.

In correctional settings, MAT is not just a medical service. It is also a public safety and reentry strategy. When people leave custody with a treatment plan, they are more likely to connect with community care, and that can reduce emergency room visits, overdose deaths, and recidivism. New Mexico's current policy direction reflects that broader view.

What New Mexico Requires Now

New Mexico's administrative rule for medication-assisted treatment in correctional settings became effective on September 1, 2024. The rule says that by December 31, 2025, NMCD-operated correctional facilities must provide continuation of MAT or MOUD for people who were already receiving treatment in the community or in a county detention facility before booking. It also says that by June 30, 2026, NMCD-operated correctional facilities must initiate MAT or MOUD for qualified individuals diagnosed with substance use disorder.

That is an important distinction. Continuation means a person who was already prescribed treatment should not have that treatment abruptly stopped simply because they entered custody. Initiation means some incarcerated people who were not previously on medication may still be evaluated and started on treatment if they qualify.

The rule also states that, for people specifically identified with opioid use disorder, FDA-approved MAT or MOUD should be offered. It further allows current inmates and detainees, beginning July 1, 2026, to request substance use disorder screening at any time during incarceration, including before release, with referral for screening and assessment if indicated.

How the New Mexico Corrections Department Is Implementing It

The New Mexico Corrections Department has published a MAT/MOUD program policy that focuses first on continuity of care for people entering NMCD custody who were already receiving MOUD under a qualified medical provider. The department's 2025 annual report says the agency launched a MOUD pilot program, with more than 200 participants between January and October 2025, and later launched a methadone maintenance program in December 2025. The report also says the department is working with the New Mexico Health Care Authority and expanding access as staffing and infrastructure allow.

That matters because correctional health programs are often limited by logistics. Medication storage, chain of custody, clinical staffing, security procedures, and coordination with outside providers all have to work together. New Mexico's policy documents show that the state is trying to build a system that is both medically sound and operationally secure.

What Medications Are Typically Used

MAT in jails and prisons can include several FDA-approved medications, depending on the disorder being treated. For opioid use disorder, common options include buprenorphine, methadone, and naltrexone. The specific medication should be chosen by a healthcare practitioner in consultation with the patient, taking into account health needs, safety, security, and community treatment options.

In practice, this means New Mexico's correctional system is not limited to one medication model. The state's rules are written broadly enough to support individualized treatment rather than a one-size-fits-all approach.

• Continuation of treatment for people already on MOUD is a priority.
• Initiation of treatment for qualified incarcerated individuals is required by the 2026 deadline.
• Medication choice should be based on clinical need and correctional safety.
• Screening and assessment are intended to be available throughout incarceration.

How This Affects County Jails

County jails are often the first point of contact with the correctional system, and they play a critical role in treatment continuity. New Mexico's rule specifically references people receiving MAT or MOUD in the community or in a county detention facility before booking. That means county jails are part of the treatment pipeline, even if the state prison system is the main entity responsible for later continuation and initiation requirements.

For people in short-term custody, the challenge is especially urgent. Jail stays may be brief, but the health risks are immediate. If a person is stabilized on medication in the community and then loses access in jail, the consequences can be severe. New Mexico's policy direction suggests a growing expectation that jails coordinate more closely with community providers and state systems.

Reentry Is Part of the Treatment Plan

One of the strongest arguments for MAT in correctional settings is reentry planning. Treatment should not end at the gate. A person leaving jail or prison may need a bridge prescription, a referral to a community clinic, insurance coordination, transportation help, and follow-up appointments. Without those steps, the gains made during incarceration can disappear quickly.

New Mexico's correctional strategy appears to recognize that continuity after release is essential. The state's annual report describes discharge coordination and ongoing treatment planning as central components of the MOUD effort. That is consistent with best practice: the transition back to the community is often the highest-risk period for overdose and relapse.

What to Watch Next in New Mexico

Even with clear rules on the books, implementation is the real test. The key questions for 2026 are practical ones: Are all NMCD facilities fully able to start and continue treatment? Are county jails coordinating effectively with state prisons and community providers? Are enough clinicians and support staff available? Are people being screened consistently and offered the right medication at the right time?

New Mexico's approach is notable because it combines regulation, department policy, and pilot programs. That suggests the state is trying to move from a limited model to a broader correctional health framework. Still, the system is likely to keep changing as facilities expand capacity and refine procedures.

Bottom Line

Medication-assisted treatment in New Mexico jails and prisons is no longer a niche topic. It is now a defined state policy area with deadlines, operational guidance, and active implementation. For incarcerated people with substance use disorders, especially opioid use disorder, the shift could mean better continuity of care, fewer dangerous interruptions in treatment, and a stronger chance of recovery after release.

For families, advocates, and legal observers, the important takeaway is this: New Mexico is building a correctional treatment model that treats addiction as a health condition, not just a disciplinary issue. The next phase will be measured by how consistently that model reaches every eligible person in custody.

Other Relevant Articles for New Mexico

Relevant County Info

Information is sourced from publicaly available information and may be inaccurate